您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [citeline]:使用Trialtrove+和Sitedepre加快临床试验规划和选址+ - 发现报告

使用Trialtrove+和Sitedepre加快临床试验规划和选址+

医药生物 2025-04-04 citeline Zt
报告封面

Expediting ClinicalTrial Planning andSite Selection withTrialtrove+andSitetrove+ Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Challenge A mid-size biopharma company is preparing for a Phase III clinical trial in a competitivetherapeutic area. The study team is facing challenges in: Identifyingthe most suitable trial sites and investigators with strongperformance records “We are trying to branch out from always using the same sites.” HEAD OF PATIENT RECRUITMENT AND FEASIBILITY AT MID-SIZE PHARMA Benchmarkingsite start-up times and performance metrics to optimizefeasibility planning Reducingscreen failure rates and improving patient retention Streamliningdata analysis and decision-making for study start-up Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Solution: Trialtrove+and Sitetrove+ By leveraging the next-generation capabilities of Trialtrove+and Sitetrove+, the study teamcan address these challenges effectively. Optimized KOL Identification with Expert Finder UsingExpert Finder, the team identifies KOLs with a proven track record in theirtherapeutic area. With data on over 580,000 investigators, including claims,journals, publications, payments, NIH grants, congress participation, and socialmedia presence, the team shortlists experts who align with their study criteria andcan support their study. Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Data-driven Feasibility and Start-up Planning withPerformance Metrics2 Through variousPerformance Metrics, the team gains visibility into key siteperformance indicators, including start-up cycle times, dropout rates, and screenfailure rates. By layering in proprietary derived aggregated data points, they canconfidently select sites and countries with historically shorter start-up times andhigher patient retention rates, leading to a more efficient trial launch. Additionally,the Site Compare Toolallows the team to compare site capacity,experience, and trial performance among different sites, helping them make moreinformed decisions. Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Deeper Insights through Interactive Visualizations with Analytics TheAnalyticsdashboard enables the team to assess global trial trends, evaluatecompetitive landscapes, and identify potential roadblocks. Instead of manuallyextracting and manipulating data in external tools, the team now has accessto interactive charts, tables, and predictive insights directly within the platform.Clinical Trial TrendsandTrial Activity Landscape Analysisallow the team tovisualize historical trial data by disease, sponsor, drugs, patient segment, andcountry, optimizing trial planning. Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ AI-powered Insights with Ella WithElla, the AI chat assistant, the team accelerates research by quickly retrievingrelevant trial and site data, applying automated filters, and receiving answers in realtime.Ella can create searches and validate search strategies, saving the teamsignificant time that would otherwise be spent manually reviewing data. Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Enrollment Performance Benchmarking TheTrial Health Calculatorhelps benchmark trial recruitment performanceagainst industry expectations, allowing the team to better assess if enrollmentissues are trial-specific or part of broader industry trends. Additionally,Enrollment Performance Metricsprovide the team with insightsinto patients per site per month, enrollment rates, and screen failure metrics bycountry, therapeutic area, disease, and patient segment. Use Case| Expediting Clinical Trial Planningand Site Selection with Trialtrove+and Sitetrove+ Results Increased confidencein siteselection with benchmarkedperformance metrics Reductionin time spentidentifying suitable trial sitesand investigators Enhanced protocol feasibilitywith insights into screen failureand retention rates Faster decision-makingwithAI-powered research assistance More efficient study start-upthrough streamlined analyticsand automation Unbiased site selectionthroughproprietarySite Compare Tool Conclusion Trialtrove+and Sitetrove+empower clinical teams with exclusive insights from proprietarydatasets, AI-powered chat assistant, and advanced analytics, enabling faster, smarter, andmore confident trial planning. With these innovations, biopharma companies can enhancesite and investigator selection, optimize study feasibility, benchmark performance, andultimately accelerate clinical trial success. “It gives meconfidencein bringing new countries, start-up timelines, patient countsto my leadership to get a green light on the strategy. We can build this benchmarkinginto our regulatory submissions: We anticipate that t